Search

Manuel B Litchman

from Teaneck, NJ
Age ~71
Get Report
Related to:
Wendy Berk, 50Allen B Berk, 62Leonard Berk, 59Eleanor Berk, 87Walter Berk, 95
Connected to:
Ben J Litchman, 38Jonathan D Litchman, 60Kathleen A Litchman, 59Barton Litchmore, 91Debbie A Litchmore, 59Jean G Litchmore, 75Verona J Litchmore, 63Sherry Litchner, 51Aric J Litchy, 38Eileen G Litchy, 59

Manuel Litchman Phones & Addresses

  • 797 Winthrop Rd, Teaneck, NJ 07666 (201) 801-0930
  • Englewood, NJ
  • New York, NY
  • Poughkeepsie, NY

Work

Position: Medical Professional

Education

Degree: Graduate or professional degree

Emails

p***[email protected]

Publications

Us Patents

Cancer Treatment With Epothilones

View page
US Patent:
6635666, Oct 21, 2003
Filed:
Aug 9, 2001
Appl. No.:
09/925119
Inventors:
Terence OReilly - Basel, CH
Markus Wartmann - Riehen, CH
Manuel Litchman - Teaneck NJ
Pamela Cohen - Tenafly NJ
Assignee:
Novartis AG - Basel
International Classification:
A61K 31425
US Classification:
514365
Abstract:
The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

Cancer Treatment With Epothilones

View page
US Patent:
7091226, Aug 15, 2006
Filed:
Mar 24, 2005
Appl. No.:
11/089269
Inventors:
Terence O'Reilly - Basel, CH
Markus Wartmann - Riehen, CH
Manuel Litchman - Teaneck NJ, US
Pamela Cohen - Tenafly NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A01N 43/78
A61K 31/425
US Classification:
514365
Abstract:
The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

Cancer Treatment With Epothilones

View page
US Patent:
7875601, Jan 25, 2011
Filed:
Apr 19, 2006
Appl. No.:
11/406896
Inventors:
Terence O'Reilly - Basel, CH
Markus Wartmann - Riehen, CH
Manuel Litchman - Teaneck NJ, US
Pamela Cohen - Tenafly NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A01N 43/00
A61K 31/33
US Classification:
514183
Abstract:
The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

Cancer Treatment With Epothilones

View page
US Patent:
20040024033, Feb 5, 2004
Filed:
Aug 1, 2003
Appl. No.:
10/633114
Inventors:
Terence O'Reilly - Basel, CH
Markus Wartmann - Riehen, CH
Manuel Litchman - Teaneck NJ, US
Pamela Cohen - Tenafly NJ, US
International Classification:
A61K031/427
US Classification:
514/365000
Abstract:
The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

Cancer Treatment With Epothilones

View page
US Patent:
63028387, Oct 16, 2001
Filed:
Jan 19, 1999
Appl. No.:
9/233993
Inventors:
Terence O'Reilly - Basel, CH
Markus Wartmann - Riehen, CH
Manuel Litchman - Teaneck NJ
Pamela Cohen - Tenafly NJ
Assignee:
Novartis AG - Basel
International Classification:
A61K 31425
US Classification:
574365
Abstract:
The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
Control profile
Manuel B Litchman from Teaneck, NJ, age ~71 Get Report